Daunomycin
Showing 1 - 25 of 84
Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)
Completed
- Leukemia
- +2 more
- Selinexor
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- +10 more
- (no location specified)
Jan 13, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Azacitidine
- +6 more
- (no location specified)
Nov 15, 2022
Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia
Completed
- Acute Lymphoblastic Leukemia
- Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
- Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2022
B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Inotuzumab ozogamicin
- +6 more
-
Nashville, Tennessee
- +3 more
Aug 14, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Cytarabine
- +4 more
-
Birmingham, Alabama
- +8 more
Jan 24, 2023
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)
Terminated
- Acute Lymphocytic Leukemia
- Adult Lymphoblastic Lymphoma
- DNR
- +12 more
-
La Jolla, California
- +3 more
Apr 26, 2022
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin
Recruiting
- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia
- Cyclophosphamide
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)
Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Cytarabine
- +4 more
-
Brewer, Maine
- +8 more
Jun 18, 2021
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,
Active, not recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +5 more
- Biopsy
- +7 more
-
Lewes, Delaware
- +42 more
Mar 15, 2022
Untreated Adult Acute Myeloid Leukemia Trial in Scottsdale, Rochester (Cytarabine, Daunorubicin Hydrochloride, Laboratory
Completed
- Untreated Adult Acute Myeloid Leukemia
- Cytarabine
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 4, 2020
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia-2, High Risk Myelodysplastic Syndrome Trial in New Haven, Baltimore,
Completed
- Acute Myeloid Leukemia
- +3 more
- Cytarabine
- +6 more
-
New Haven, Connecticut
- +2 more
Oct 10, 2020
Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Scottsdale, Arizona
- +43 more
Nov 17, 2022
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
AML Trial in Tianjin (Daunomycin and Cytarabine (DA Regimen), Daunomycin and Cytarabine (Intermediate Dose of DA Regimen))
Unknown status
- AML
- Daunomycin and Cytarabine (DA Regimen)
- Daunomycin and Cytarabine (Intermediate Dose of DA Regimen)
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Mar 21, 2019
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States
Completed
- Acute Lymphoblastic Leukemia
- Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- Alemtuzumab
- +20 more
-
Palo Alto, California
- +100 more
Aug 3, 2022
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Australia,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Cyclophosphamide
- +12 more
-
Phoenix, Arizona
- +27 more
Apr 2, 2021
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in United
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Calaspargase Pegol-mknl
- +14 more
-
Birmingham, Alabama
- +26 more
Apr 2, 2021